Goodbody Health Stock price Canadian Securities Exchange
Equities
SWEL
CA3821591011
Pharmaceuticals
Sales 2020 | 1.99M 2.52M 3.41M | Sales 2021 | 17.06M 21.56M 29.17M | Capitalization | 13.76M 17.39M 23.53M |
---|---|---|---|---|---|
Net income 2020 | -4M -5.06M -6.84M | Net income 2021 | -2M -2.53M -3.42M | EV / Sales 2020 | 5.41 x |
Net cash position 2020 | 1.37M 1.74M 2.35M | Net cash position 2021 | 5.73M 7.24M 9.8M | EV / Sales 2021 | 0.47 x |
P/E ratio 2020 |
-1.4
x | P/E ratio 2021 |
-5.64
x | Employees | - |
Yield 2020 * |
-
| Yield 2021 |
-
| Free-Float | 70.26% |
Managers | Title | Age | Since |
---|---|---|---|
George Thomas
CEO | Chief Executive Officer | 35 | 21-01-25 |
Geremy Thomas
FOU | Founder | 64 | 11-02-13 |
John Pettit
CTO | Chief Tech/Sci/R&D Officer | - | - |
Members of the board | Title | Age | Since |
---|---|---|---|
Geremy Thomas
FOU | Founder | 64 | 11-02-13 |
George Thomas
CEO | Chief Executive Officer | 35 | 21-01-25 |
Anne Tew
SEC | Corporate Secretary | - | 18-10-31 |
1st Jan change | Capi. | |
---|---|---|
+23.32% | 5.39B | |
-12.48% | 4.67B | |
-6.70% | 3.29B | |
-16.43% | 2.6B | |
-2.41% | 2.52B | |
-7.97% | 1.7B | |
+24.37% | 1.63B | |
-8.02% | 1.61B | |
-4.40% | 1.56B |